AIM ImmunoTech Inc. ( AIM) - Stock Earnings
Stock symbol AIM is outdated, potentially delisted? Maybe it is available on other exchange?
AIM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
AIM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q2 | -1.8 million USD | 50000 USD |
| 2024Q3 | -3.7 million USD | 35000 USD |
| 2024Q4 | -6.0 million USD | 45000 USD |
AIM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -21.1 million USD | 141000 USD |
| 2023 | -29.0 million USD | 202000 USD |
| 2024 | -17.3 million USD | 170000 USD |
AIM
Price: $0.09
52 week price:
Earnings Per Share: -0.31 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36383
Market Capitalization: 6.5 million